Increase the quality of banked cord blood units without limiting HLA diversity: how cord blood banks could face this dilemma
| dc.contributor.author | Magalon, Jeremy | |
| dc.contributor.author | Gamerre, Marc | |
| dc.contributor.author | Picard, Christophe | |
| dc.contributor.author | Chabannon, Christian | |
| dc.date.accessioned | 2022-09-13T16:45:44Z | |
| dc.date.available | 2022-09-13T16:45:44Z | |
| dc.date.issued | 2014-02 | |
| dc.date.updated | 2022-09-13T16:45:44Z | |
| dc.identifier.issn | 0041-1132 | |
| dc.identifier.issn | 1537-2995 | |
| dc.identifier.uri | ||
| dc.language | en | |
| dc.publisher | Wiley | |
| dc.relation.ispartof | Transfusion | |
| dc.relation.isversionof | 10.1111/trf.12439 | |
| dc.subject | Science & Technology | |
| dc.subject | Life Sciences & Biomedicine | |
| dc.subject | Hematology | |
| dc.subject | TRANSFUSIONS | |
| dc.subject | PLATELETS | |
| dc.subject | TRIAL | |
| dc.title | Increase the quality of banked cord blood units without limiting HLA diversity: how cord blood banks could face this dilemma | |
| dc.type | Journal article | |
| pubs.begin-page | 495 | |
| pubs.end-page | 496 | |
| pubs.issue | 2 | |
| pubs.organisational-group | Duke | |
| pubs.organisational-group | School of Medicine | |
| pubs.organisational-group | Basic Science Departments | |
| pubs.organisational-group | Clinical Science Departments | |
| pubs.organisational-group | Institutes and Centers | |
| pubs.organisational-group | Pathology | |
| pubs.organisational-group | Pediatrics | |
| pubs.organisational-group | Duke Cancer Institute | |
| pubs.organisational-group | Institutes and Provost's Academic Units | |
| pubs.organisational-group | Initiatives | |
| pubs.organisational-group | Duke Innovation & Entrepreneurship | |
| pubs.organisational-group | Pediatrics, Transplant and Cellular Therapy | |
| pubs.organisational-group | Regeneration Next Initiative | |
| pubs.publication-status | Published | |
| pubs.volume | 54 |
Files
Original bundle
1 - 1 of 1